Combination breast cancer chemotherapy with doxorubicin and cyclophosphamide causes bone and bone marrow damage in a female rat model.

Chia-Ming Fan, Kristen Georgiou, Howard Morris, Ross McKinnon, Dorothy Keefe, Peter Howe, Cory Xian

    Research output: Contribution to journalArticle

    11 Citations (Scopus)

    Abstract

    Purpose: Anthracyclines (including doxorubicin) are still the backbone of commonly used breast cancer chemotherapy regimens. Despite increasing use of doxorubicin and cyclophosphamide (AC) combinations for treating breast cancer, their potential to cause adverse skeletal effects remains unclear. Methods: This study examined the effects of treatments with the AC regimen on bone and bone marrow in adult female rats. Results: AC treatment for four cycles (weekly intravenous injection of 2 mg/kg doxorubicin and 20 mg/kg cyclophosphamide) resulted in a reduced volume of trabecular bone at the metaphysis, which was associated with reduced serum levels of 25-hydroxy vitamin D3 and alkaline phosphatase. Reductions in densities of osteocytes and bone lining cells were also observed. In addition, bone marrow was severely damaged, including a severe reduction in bone marrow cellularity and an increase in marrow adipocyte content. Accompanying these changes, there were increases in mRNA expression of adipogenesis regulatory genes (PPARγ and FABP4) and an inflammatory cytokine (TNFα) in metaphysis bone and bone marrow. Conclusions: This study indicates that AC chemotherapy may induce some bone loss, due to reduced bone formation, and bone marrow damage, due to increased marrow adiposity. Preventive strategies for preserving the bone and bone marrow microenvironment during anthracycline chemotherapy warrant further investigation.

    Original languageEnglish
    Pages (from-to)41-51
    Number of pages11
    JournalBreast Cancer Research and Treatment
    Volume165
    Issue number1
    Early online date2017
    DOIs
    Publication statusPublished - 26 May 2017

    Fingerprint Dive into the research topics of 'Combination breast cancer chemotherapy with doxorubicin and cyclophosphamide causes bone and bone marrow damage in a female rat model.'. Together they form a unique fingerprint.

  • Cite this